Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nuvalent, Inc. - Class A Common Stock (NQ:NUVL)

91.22 -2.80 (-2.98%)
Streaming Delayed Price Updated: 3:52 PM EDT, Jun 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 494,677
Open 93.38
Bid (Size) 90.76 (100)
Ask (Size) 91.23 (300)
Prev. Close 94.02
Today's Range 90.40 - 94.08
52wk Range 71.13 - 113.02
Shares Outstanding 3,129,384
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally ↗
This clinical-stage biotech develops targeted therapies for RAS/MAPK pathway cancers, advancing a pipeline of novel oncology candidates. 
Via The Motley Fool
Topics Regulatory Compliance
Nuvalent Inc-A (NASDAQ:NUVL) Stock Edges Higher After Q1 2026 Earnings Miss as Investors Focus on Pipeline Milestones ↗
Via Chartmill
Topics Earnings

Performance

YTD
-9.5%
-9.5%
1 Month
-10.1%
-10.1%
3 Month
-8.9%
-8.9%
6 Month
-14.6%
-14.6%
1 Year
+18.7%
+18.7%

More News

Read More
News headline image
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗
Via The Motley Fool
News headline image
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗
Via The Motley Fool
Why Did Nuvalent Stock Surge 15% Today? ↗
Via Stocktwits
News headline image
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗
Via The Motley Fool
News headline image
Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
Via The Motley Fool
News headline image
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Stock Gets Booted in Latest Fund Update ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer ↗
Via Benzinga
News headline image
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
Via Benzinga
News headline image
Nuvalent Unveils A New Promise For Hard-To-Treat Lung Cancer ↗
Via Investor's Business Daily
News headline image
Wondering what's happening in today's after-hours session? ↗
Via Chartmill

Frequently Asked Questions

Is Nuvalent, Inc. - Class A Common Stock publicly traded?
Yes, Nuvalent, Inc. - Class A Common Stock is publicly traded.
What exchange does Nuvalent, Inc. - Class A Common Stock trade on?
Nuvalent, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nuvalent, Inc. - Class A Common Stock?
The ticker symbol for Nuvalent, Inc. - Class A Common Stock is NUVL on the Nasdaq Stock Market
What is the current price of Nuvalent, Inc. - Class A Common Stock?
The current price of Nuvalent, Inc. - Class A Common Stock is 91.22
When was Nuvalent, Inc. - Class A Common Stock last traded?
The last trade of Nuvalent, Inc. - Class A Common Stock was at 06/05/26 03:52 PM ET
What is the market capitalization of Nuvalent, Inc. - Class A Common Stock?
The market capitalization of Nuvalent, Inc. - Class A Common Stock is 285.46M
How many shares of Nuvalent, Inc. - Class A Common Stock are outstanding?
Nuvalent, Inc. - Class A Common Stock has 285M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.